Abstract:The aim of our work is to prepare mucoadhesive particles with biopolymers and 5-Aminosalicylic acid (5ASA) using the ionotropic gelation technique to ensure a controlled drug release at the colon level with potential applications in the treatment of intestinal bowel disease (IBD). The preparation of particles through the crosslinking of Chitosan (CS) with sodium tripolyphosphate (TPP) using different mass ratios and the influence of the k-Carrageenan (kCG) layer were studied. UV–VIS spectrometry was employed t… Show more
“…Some strong signals can be observed corresponding to the stretching vibrations of different bonds: 2880 cm −1 (C–H stretch), 1278 and 1240 cm −1 (C–O–C stretches), and 1097 cm −1 (C–O stretch) [ 46 , 47 , 48 ]. On the other hand, in the TPP spectrum ( Figure 2 II(c)), it is possible to observe absorption bands at 1208 cm −1 belonging to the stretching vibrations of P═O, at 1137 cm −1 symmetric and antisymmetric stretching vibrations of the PO 2 group, at 1094 cm −1 symmetric and antisymmetric stretching vibrations of the PO 3 group, and at 889 cm −1 antisymmetric stretching vibrations of the P–O–P bond [ 49 , 50 ]. When d and e spectra belonging to the hydrogels prepared are compared with the a–c spectra of the initial components, it is clearly noted that although the characteristic signals of both initial polymers are observed, their largest amount corresponds to PF, which has the highest proportion in the final material.…”
Intra-articular administration of anti-inflammatory drugs is a strategy that allows localized action on damaged articular cartilage and reduces the side effects associated with systemic drug administration. The objective of this work is to prepare injectable thermosensitive hydrogels for the long-term application of dexamethasone. The hydrogels were prepared by mixing chitosan (CS) and Pluronic-F127 (PF) physically. In addition, tripolyphosphate (TPP) was used as a crosslinking agent. Chitosan added to the mix increased the gel time compared to the pluronic gel alone. The incorporation of TPP into the material modified the morphology of the hydrogels formed. Subsequently, MTS and Live/Dead® experiments were performed to investigate the toxicity of hydrogels against human chondrocytes. The in vitro releases of dexamethasone (DMT) from CS-PF and CS-PF-TPP gels had an initial burst and took more time than that from the PF hydrogel. In vivo studies showed that hydrogels retained the fluorescent compound longer in the joint than when administered in PBS alone. These results suggest that the CS-PF and CS-PF-TPP hydrogels loaded with DMT could be a promising drug delivery platform for the treatment of osteoarthritis.
“…Some strong signals can be observed corresponding to the stretching vibrations of different bonds: 2880 cm −1 (C–H stretch), 1278 and 1240 cm −1 (C–O–C stretches), and 1097 cm −1 (C–O stretch) [ 46 , 47 , 48 ]. On the other hand, in the TPP spectrum ( Figure 2 II(c)), it is possible to observe absorption bands at 1208 cm −1 belonging to the stretching vibrations of P═O, at 1137 cm −1 symmetric and antisymmetric stretching vibrations of the PO 2 group, at 1094 cm −1 symmetric and antisymmetric stretching vibrations of the PO 3 group, and at 889 cm −1 antisymmetric stretching vibrations of the P–O–P bond [ 49 , 50 ]. When d and e spectra belonging to the hydrogels prepared are compared with the a–c spectra of the initial components, it is clearly noted that although the characteristic signals of both initial polymers are observed, their largest amount corresponds to PF, which has the highest proportion in the final material.…”
Intra-articular administration of anti-inflammatory drugs is a strategy that allows localized action on damaged articular cartilage and reduces the side effects associated with systemic drug administration. The objective of this work is to prepare injectable thermosensitive hydrogels for the long-term application of dexamethasone. The hydrogels were prepared by mixing chitosan (CS) and Pluronic-F127 (PF) physically. In addition, tripolyphosphate (TPP) was used as a crosslinking agent. Chitosan added to the mix increased the gel time compared to the pluronic gel alone. The incorporation of TPP into the material modified the morphology of the hydrogels formed. Subsequently, MTS and Live/Dead® experiments were performed to investigate the toxicity of hydrogels against human chondrocytes. The in vitro releases of dexamethasone (DMT) from CS-PF and CS-PF-TPP gels had an initial burst and took more time than that from the PF hydrogel. In vivo studies showed that hydrogels retained the fluorescent compound longer in the joint than when administered in PBS alone. These results suggest that the CS-PF and CS-PF-TPP hydrogels loaded with DMT could be a promising drug delivery platform for the treatment of osteoarthritis.
“…Stavarache et al [ 176 ] described mucoadhesive chitosan particles with κ-carrageenan coating attached by polyelectrolyte complexation as potential carrier for 5-aminosalicylic acid. The aim of the study was to deliver the active ingredient to colon without releasing it in upper parts of the gastrointestinal tract.…”
Section: Gum-based Micro- and Nanoparticles In Drug Deliverymentioning
Gums are polysaccharide compounds obtained from natural sources, such as plants, algae and bacteria. Because of their excellent biocompatibility and biodegradability, as well as their ability to swell and their sensitivity to degradation by the colon microbiome, they are regarded as interesting potential drug carriers. In order to obtain properties differing from the original compounds, blends with other polymers and chemical modifications are usually applied. Gums and gum-derived compounds can be applied in the form of macroscopic hydrogels or can be formulated into particulate systems that can deliver the drugs via different administration routes. In this review, we present and summarize the most recent studies regarding micro- and nanoparticles obtained with the use of gums extensively investigated in pharmaceutical technology, their derivatives and blends with other polymers. This review focuses on the most important aspects of micro- and nanoparticulate systems formulation and their application as drug carriers, as well as the challenges related to these formulations.
“…86 Chitosan NPs are widely applied as colon-targeted DDSs in IBD treatment because of their good biocompatibility, desirable biodegradability, and strong muco-adhesiveness. 69,87,88 Moreover, chitosan NPs presenting a positively charged amino group (–NH 3+ ) can specifically interact with the negatively charged mucosal surface of the inflamed colon contributing to prolonged drug release, and enhanced colonic drug absorption. 89,90 However, chitosan is known for its solubility in acidic media, which may exhibit a premature release and/or burst release of the agents before reaching the colon.…”
As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel disease (IBD) is characterized by recurrent intestinal mucosal inflammation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.